United Therapeutics (UTHR)
Builds pulmonary-hypertension medicines and investigational organ-manufacturing platforms.
$500.00
After hours+2.35 (+0.47%)
At close$497.65(+0.92%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
$6.44
Revenue estimate
$789.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26May '26Aug '26Nov '26
Reported$6.19$6.63$6.41$7.16$7.70$5.82$7.27Pending
Estimate$6.40$6.29$7.29$6.89$7.13$7.00$6.86$6.44
Surprise−3.3%+5.4%−12.1%+3.9%+8.0%−16.9%+6.0%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26May '26Aug '26Nov '26
Reported$735.9M$794.4M$798.6M$799.5M$790.2M$781.5M$783.3MPending
Estimate$734.7M$778.7M$801.9M$814.8M$813.1M$797.4M$804.6M$789.5M
Surprise+0.2%+2.0%−0.4%−1.9%−2.8%−2.0%−2.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $7.26 | — | — |
| Sep 2027 | $6.62 | — | — |
| Jun 2027 | $6.39 | — | — |
| Mar 2027 | $6.33 | — | — |
| Dec 2026 | $6.71 | — | — |
| Nov 2026 | $6.44 | — | — |
| Aug 2026 | $6.86 | $7.27 | +6.0% |
| May 2026 | $7.00 | $5.82 | −16.9% |
| Feb 2026 | $7.13 | $7.70 | +8.0% |
| Oct 2025 | $6.89 | $7.16 | +3.9% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $7.26 | — | — | $851.2M | — | — | — |
| Sep 2027 | $6.62 | — | — | $776.6M | — | — | — |
| Jun 2027 | $6.39 | — | — | $744.8M | — | — | — |
| Mar 2027 | $6.33 | — | — | $733.3M | — | — | — |
| Dec 2026 | $6.71 | — | — | $792.4M | — | — | — |
| Nov 4, 2026 | $6.44 | — | — | $789.5M | — | — | — |
| Aug 5, 2026 | $6.86 | $7.27 | +6.0% | $804.6M | $783.3M | −2.7% | +0.1% |
| May 6, 2026 | $7.00 | $5.82 | −16.9% | $797.4M | $781.5M | −2.0% | +4.3% |
| Feb 25, 2026 | $7.13 | $7.70 | +8.0% | $813.1M | $790.2M | −2.8% | +13.0% |
| Oct 29, 2025 | $6.89 | $7.16 | +3.9% | $814.8M | $799.5M | −1.9% | +9.6% |
| Jul 30, 2025 | |||||||
| Apr 30, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 21, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 22, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Oct 28, 2020 | |||||||
| Jul 29, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Oct 30, 2019 | |||||||
| Jul 31, 2019 | |||||||
| May 1, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Oct 31, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 2, 2018 | |||||||
| Feb 21, 2018 | |||||||
| Oct 25, 2017 | |||||||
| Jul 27, 2017 | |||||||
| Apr 26, 2017 | |||||||
| Feb 22, 2017 | |||||||
| Oct 27, 2016 | |||||||
| Jul 28, 2016 | |||||||
| Apr 28, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Oct 27, 2015 | |||||||
| Jul 28, 2015 |